Merrimack Pharmaceuticals
MACK
#8761
Rank
ยฃ0.17 B
Marketcap
ยฃ11.55
Share price
0.00%
Change (1 day)
2.46%
Change (1 year)

Merrimack Pharmaceuticals (MACK) - Total debt

Total debt on the balance sheet as of March 2019 : ยฃ12.67 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's total debt is ยฃ12.67 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Merrimack Pharmaceuticals - Total debt on balance sheet (from 2010 to 2019)

Total debt by year

Year Total debt Change
2018-12-31ยฃ11.71 M
2017-12-31N/A-100%
2016-12-31ยฃ0.17 B1.08%
2015-12-31ยฃ0.17 B125.57%
2014-12-31ยฃ77.07 M13.85%
2013-12-31ยฃ67.7 M174.56%
2012-12-31ยฃ24.65 M79746.18%
2011-12-31ยฃ0.03 M-90.29%
2010-12-31ยฃ0.31 M-62.02%
2009-12-31ยฃ0.83 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sanofi
SNY
ยฃ20.54 B 162,006.15%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
ยฃ93.27 M 635.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
ยฃ0.51 B 4,000.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
ยฃ29.53 M 133.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ0.26 M-97.90%๐Ÿ‡บ๐Ÿ‡ธ USA